JP2012510477A5 - - Google Patents

Download PDF

Info

Publication number
JP2012510477A5
JP2012510477A5 JP2011538797A JP2011538797A JP2012510477A5 JP 2012510477 A5 JP2012510477 A5 JP 2012510477A5 JP 2011538797 A JP2011538797 A JP 2011538797A JP 2011538797 A JP2011538797 A JP 2011538797A JP 2012510477 A5 JP2012510477 A5 JP 2012510477A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
compound
alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011538797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012510477A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2009/001572 external-priority patent/WO2010063069A1/en
Publication of JP2012510477A publication Critical patent/JP2012510477A/ja
Publication of JP2012510477A5 publication Critical patent/JP2012510477A5/ja
Pending legal-status Critical Current

Links

JP2011538797A 2008-12-02 2009-12-02 放射性医用薬剤としての窒素含有大環状結合体 Pending JP2012510477A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008906239 2008-12-02
AU2008906239A AU2008906239A0 (en) 2008-12-02 Radiopharmaceuticals
PCT/AU2009/001572 WO2010063069A1 (en) 2008-12-02 2009-12-02 Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015022109A Division JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Publications (2)

Publication Number Publication Date
JP2012510477A JP2012510477A (ja) 2012-05-10
JP2012510477A5 true JP2012510477A5 (https=) 2013-01-24

Family

ID=42232814

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011538797A Pending JP2012510477A (ja) 2008-12-02 2009-12-02 放射性医用薬剤としての窒素含有大環状結合体
JP2015022109A Active JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015022109A Active JP5981580B2 (ja) 2008-12-02 2015-02-06 放射性医用薬剤としての窒素含有大環状結合体

Country Status (9)

Country Link
US (7) US9701694B2 (https=)
EP (2) EP3098225B1 (https=)
JP (2) JP2012510477A (https=)
CN (1) CN102300866B (https=)
AU (1) AU2009322081C1 (https=)
CA (1) CA2745495C (https=)
DK (1) DK3098225T3 (https=)
ES (1) ES2712881T3 (https=)
WO (1) WO2010063069A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013003912A1 (en) * 2011-07-07 2013-01-10 Australian Nuclear Science And Technology Organisation Cryptate compounds
JP6051227B2 (ja) * 2011-12-06 2016-12-27 ザ ユニバーシティ オブ メルボルン 金属放射性医薬品のためのケージアミン配位子の官能化
JP6047581B2 (ja) * 2011-12-06 2016-12-21 ザ ユニバーシティ オブ メルボルン 金属放射性医薬品のためのケージアミン配位子
US9422286B2 (en) 2014-01-27 2016-08-23 Washington University Metal-binding bifunctional compounds as diagnostic agents for Alzheimer's disease
GB201417067D0 (en) 2014-09-26 2014-11-12 South African Nuclear Energy Radiopharmaceutical conjugate
AU2017354941B2 (en) * 2016-11-04 2021-02-11 Clarity Pharmaceuticals Ltd Formulations for radiotherapy and diagnostic imaging
CN115322244B (zh) * 2017-06-06 2025-10-28 透明医药有限公司 放射性药物、放射成像剂及其用途
WO2019195890A1 (en) * 2018-04-11 2019-10-17 Clarity Pharmaceuticals Pty Ltd Formulations and kits for radiotherapy and diagnostic imaging
CN111989324A (zh) 2018-04-11 2020-11-24 墨尔本大学 靶向化合物及其生产方法
US20220313600A1 (en) * 2019-05-24 2022-10-06 Clarity Pharmaceuticals Limited Formulations of psma imaging agents
CN115175910A (zh) * 2019-11-08 2022-10-11 昆士兰大学 放射性标记的靶向配体
CN115003684A (zh) * 2020-01-26 2022-09-02 主线生物科学有限公司 同位素标记的选择性cxcr4结合肽偶联物及其制备和使用方法
MX2022013783A (es) * 2020-05-06 2023-04-19 Univ Cornell Compuestos tratanosticos que contienen cobre y metodos de uso.
EP4196175A4 (en) * 2020-08-14 2025-07-30 Clarity Pharmaceuticals Ltd RADIOPHARMACEUTICAL COMPOUNDS, THEIR USES AND PROCESSES FOR THEIR PRODUCTION
AU2023322240A1 (en) * 2022-08-11 2025-02-20 Clarity Pharmaceuticals Limited Dimeric radiopharmaceuticals, compositions thereof and uses thereof
CN116589508A (zh) * 2023-05-16 2023-08-15 洛阳师范学院 一种基于半夹心铑构筑单元的矩形分子大环化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001719A1 (en) 1977-10-26 1979-05-02 The Australian National University Metal complexes, their preparation and production of hydrogen peroxide therewith
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates
US5245055A (en) * 1990-12-18 1993-09-14 E. R. Squibb & Sons, Inc. Process for preparing a cis oxabicyclo olefinic acid and ester from an oxabicyclo pyranol
JPH04244085A (ja) 1990-12-21 1992-09-01 Doujin Kagaku Kenkyusho:Kk 蛍光性化合物、錯体、試薬および該試薬を用いる特異的結合アッセイ
HUT76318A (en) * 1994-04-22 1997-08-28 Searle & Co Diagnostic image analysis with metal complexes
WO1995031202A1 (en) 1994-05-17 1995-11-23 Commonwealth Scientific And Industrial Research Organisation Cage compounds, processes for their preparation and their use as antiviral agents
AUPP803899A0 (en) * 1999-01-05 1999-01-28 Australian National University, The Cryptate compounds and methods for diagnosis and therapy.
US6107326A (en) * 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
GB0116815D0 (en) 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
EP1331012A1 (en) * 2002-01-29 2003-07-30 BRACCO IMAGING S.p.A. Responsive paramagnetic MRI contrast agents
FI20031528A0 (fi) * 2003-10-17 2003-10-17 Ctt Cancer Targeting Tech Oy Terapeuttinen liposomikoostumus ja menetelmä sen valmistamiseksi
US9056129B2 (en) * 2007-02-09 2015-06-16 Northeastern University Precision-guided nanoparticle systems for drug delivery

Similar Documents

Publication Publication Date Title
JP2012510477A5 (https=)
JPH02501141A (ja) テトラ‐アザ大環状化合物およびその金属錯体
JPWO1999061061A1 (ja) 薬物複合体
JP5981580B2 (ja) 放射性医用薬剤としての窒素含有大環状結合体
EA003398B1 (ru) Лекарственный комплекс c полимерным носителем
JP2020508985A5 (https=)
JP2008533191A5 (https=)
AU2019383466B2 (en) Therapeutic dendrimer
US20200069698A1 (en) Texaphyrin-pt(iv) conjugates and compositions for use in overcoming platinum resistance
JP2020531591A (ja) 相乗的抗癌活性を有する中間体薬剤およびポリエチレングリコール共役相乗的抗癌薬、ならびにその製造方法およびその使用
JP2010511687A5 (https=)
CA3120881A1 (en) Dendrimer for therapy and imaging
JP6316479B2 (ja) カルマンガホジピル、新たな化学実体、および他の混合金属錯体、調製の方法、組成物、および処置の方法
US20160220689A1 (en) Macromolecules of dendrimer-platinum conjugates
DK2788354T3 (en) FUNCTIONALIZATION OF CAGE AMINIGANDS FOR METALLO-RADIOPHARMACEUTICAL AGENTS
CZ286404B6 (en) Platinum complex compounds, process of their preparation and pharmaceutical preparation containing thereof
JP2000509030A (ja) グリコペプチド化合物
WO2007097450A1 (ja) 抗マラリア活性化合物、及びそれを有効成分とする抗マラリア薬
JP2015500246A5 (https=)
EP4034169B1 (en) Therapeutic dendrimer
AU2012278938A1 (en) Cryptate compounds
JP2005524622A5 (https=)
JP2006520768A (ja) 金属イオンのキレート化剤として有用な窒素含有多環式誘導体およびそれらの用途
US20250066411A1 (en) Glycomimetic binders for l-sign
CN119033948A (zh) 一种多臂聚乙二醇药物偶联物及其制备方法和应用